Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Aug;7(8):2522-8.

Adenosine A1 receptor-mediated inhibition of adenylate cyclase in rabbit retina

Adenosine A1 receptor-mediated inhibition of adenylate cyclase in rabbit retina

C Blazynski. J Neurosci. 1987 Aug.

Abstract

The purine adenosine has been postulated as playing a role in CNS neurotransmission or modulation. Evidence is now provided that inhibition of adenylate cyclase in rabbit retinal homogenates is mediated via adenosine A1 receptors. Nanomolar concentrations of the A1 receptor agonists, cyclohexyladenosine (CHA) and phenylisopropyladenosine (PIA), significantly inhibited the activity of forskolin-stimulated adenylate cyclase in preparations in which endogenous adenosine was destroyed by pretreatment with adenosine deaminase. With increasing concentrations of either agonist, biphasic effects on enzyme activity were observed. The effect of the mixed A1-A2 agonist, N-ethyl-carboxamidoadenosine (NECA), on forskolin-stimulated, as well as basal adenylate cyclase, was also investigated. At micromolar concentrations, NECA significantly increased the activity of adenylate cyclase. Isobutylmethylxanthine, a potent antagonist at extracellular adenosine receptors, blocked the effects observed with PIA, CHA, and NECA. The uptake of both 3H-CHA and 3H-adenosine into retinal cells was demonstrated autoradiographically. Both agonists labeled ganglion cell bodies and certain cell bodies located in the proximal portion of the inner nuclear layer.

PubMed Disclaimer

Publication types

MeSH terms